GB2558170A - Dietary supplement - Google Patents
Dietary supplement Download PDFInfo
- Publication number
- GB2558170A GB2558170A GB1602804.5A GB201602804A GB2558170A GB 2558170 A GB2558170 A GB 2558170A GB 201602804 A GB201602804 A GB 201602804A GB 2558170 A GB2558170 A GB 2558170A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- vitamin
- supplement
- amount
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 227
- 239000013589 supplement Substances 0.000 claims abstract description 159
- 239000006041 probiotic Substances 0.000 claims abstract description 42
- 235000018291 probiotics Nutrition 0.000 claims abstract description 42
- 230000036541 health Effects 0.000 claims abstract description 40
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 37
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 34
- 229940088594 vitamin Drugs 0.000 claims abstract description 34
- 229930003231 vitamin Natural products 0.000 claims abstract description 34
- 235000013343 vitamin Nutrition 0.000 claims abstract description 34
- 239000011782 vitamin Substances 0.000 claims abstract description 34
- 230000037231 joint health Effects 0.000 claims abstract description 32
- 102000038379 digestive enzymes Human genes 0.000 claims abstract description 30
- 108091007734 digestive enzymes Proteins 0.000 claims abstract description 30
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000020741 pine bark extract Nutrition 0.000 claims abstract description 26
- 229940106587 pine bark extract Drugs 0.000 claims abstract description 26
- 241000320380 Silybum Species 0.000 claims abstract description 22
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 22
- 229930064664 L-arginine Natural products 0.000 claims abstract description 21
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 21
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 20
- 239000011707 mineral Substances 0.000 claims abstract description 20
- 230000000529 probiotic effect Effects 0.000 claims abstract description 17
- RZALONVQKUWRRY-XOJLQXRJSA-N (2r,3r)-2,3-dihydroxybutanedioate;hydron;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-XOJLQXRJSA-N 0.000 claims abstract description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011575 calcium Substances 0.000 claims abstract description 15
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 15
- 229960003080 taurine Drugs 0.000 claims abstract description 15
- 230000001079 digestive effect Effects 0.000 claims abstract description 14
- DROVUXYZTXCEBX-WCCKRBBISA-N (2s)-2-amino-5-(carbamoylamino)pentanoic acid;2-hydroxybutanedioic acid Chemical compound OC(=O)C(O)CC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=O DROVUXYZTXCEBX-WCCKRBBISA-N 0.000 claims abstract description 13
- 210000004185 liver Anatomy 0.000 claims abstract description 13
- 230000036996 cardiovascular health Effects 0.000 claims abstract description 9
- 230000037180 bone health Effects 0.000 claims abstract description 8
- 230000004580 weight loss Effects 0.000 claims abstract description 8
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 7
- 210000003734 kidney Anatomy 0.000 claims abstract description 7
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 5
- 239000000835 fiber Substances 0.000 claims abstract description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 54
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 48
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 44
- 229940016409 methylsulfonylmethane Drugs 0.000 claims description 44
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 32
- 201000010099 disease Diseases 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 30
- 239000007787 solid Substances 0.000 claims description 30
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 28
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 28
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 28
- 235000019155 vitamin A Nutrition 0.000 claims description 28
- 239000011719 vitamin A Substances 0.000 claims description 28
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 claims description 27
- 229940045997 vitamin a Drugs 0.000 claims description 27
- 235000021388 linseed oil Nutrition 0.000 claims description 26
- 239000000944 linseed oil Substances 0.000 claims description 26
- 229910052742 iron Inorganic materials 0.000 claims description 24
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 23
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 23
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 22
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 22
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 22
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 22
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 22
- 229930003451 Vitamin B1 Natural products 0.000 claims description 22
- 229930003316 Vitamin D Natural products 0.000 claims description 22
- 229930003427 Vitamin E Natural products 0.000 claims description 22
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 22
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 22
- 239000011669 selenium Substances 0.000 claims description 22
- 229910052711 selenium Inorganic materials 0.000 claims description 22
- 235000011649 selenium Nutrition 0.000 claims description 22
- 229960003495 thiamine Drugs 0.000 claims description 22
- 235000010374 vitamin B1 Nutrition 0.000 claims description 22
- 239000011691 vitamin B1 Substances 0.000 claims description 22
- 235000019166 vitamin D Nutrition 0.000 claims description 22
- 239000011710 vitamin D Substances 0.000 claims description 22
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 22
- 235000019165 vitamin E Nutrition 0.000 claims description 22
- 239000011709 vitamin E Substances 0.000 claims description 22
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 21
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 21
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 21
- 239000010949 copper Substances 0.000 claims description 21
- 229910052802 copper Inorganic materials 0.000 claims description 21
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 21
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 21
- 229960002477 riboflavin Drugs 0.000 claims description 21
- 229940046009 vitamin E Drugs 0.000 claims description 21
- 229940046008 vitamin d Drugs 0.000 claims description 21
- 239000011701 zinc Substances 0.000 claims description 21
- 229910052725 zinc Inorganic materials 0.000 claims description 21
- 235000016804 zinc Nutrition 0.000 claims description 21
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 20
- 229930003471 Vitamin B2 Natural products 0.000 claims description 20
- 229930003537 Vitamin B3 Natural products 0.000 claims description 20
- 229930003761 Vitamin B9 Natural products 0.000 claims description 20
- 229960003512 nicotinic acid Drugs 0.000 claims description 20
- 235000019164 vitamin B2 Nutrition 0.000 claims description 20
- 239000011716 vitamin B2 Substances 0.000 claims description 20
- 235000019160 vitamin B3 Nutrition 0.000 claims description 20
- 239000011708 vitamin B3 Substances 0.000 claims description 20
- 235000019159 vitamin B9 Nutrition 0.000 claims description 20
- 239000011727 vitamin B9 Substances 0.000 claims description 20
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 19
- 229930003448 Vitamin K Natural products 0.000 claims description 19
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 19
- 239000011734 sodium Substances 0.000 claims description 19
- 229910052708 sodium Inorganic materials 0.000 claims description 19
- 235000019158 vitamin B6 Nutrition 0.000 claims description 19
- 239000011726 vitamin B6 Substances 0.000 claims description 19
- 235000019168 vitamin K Nutrition 0.000 claims description 19
- 239000011712 vitamin K Substances 0.000 claims description 19
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 19
- 229940011671 vitamin b6 Drugs 0.000 claims description 19
- 229940046010 vitamin k Drugs 0.000 claims description 19
- 229930003779 Vitamin B12 Natural products 0.000 claims description 18
- 235000019163 vitamin B12 Nutrition 0.000 claims description 18
- 239000011715 vitamin B12 Substances 0.000 claims description 18
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 17
- 235000019152 folic acid Nutrition 0.000 claims description 17
- 239000011724 folic acid Substances 0.000 claims description 17
- 229960000304 folic acid Drugs 0.000 claims description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 16
- 229930182816 L-glutamine Natural products 0.000 claims description 16
- 229930003571 Vitamin B5 Natural products 0.000 claims description 16
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 16
- 229960002079 calcium pantothenate Drugs 0.000 claims description 16
- 239000011675 vitamin B5 Substances 0.000 claims description 16
- 235000009492 vitamin B5 Nutrition 0.000 claims description 16
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 15
- 244000272459 Silybum marianum Species 0.000 claims description 15
- 239000011630 iodine Substances 0.000 claims description 15
- 229910052740 iodine Inorganic materials 0.000 claims description 15
- 235000013675 iodine Nutrition 0.000 claims description 15
- 241000283690 Bos taurus Species 0.000 claims description 14
- 235000001465 calcium Nutrition 0.000 claims description 14
- 235000019766 L-Lysine Nutrition 0.000 claims description 11
- 239000004472 Lysine Substances 0.000 claims description 11
- 208000008589 Obesity Diseases 0.000 claims description 10
- 235000020824 obesity Nutrition 0.000 claims description 10
- 210000002249 digestive system Anatomy 0.000 claims description 9
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 6
- 208000024891 symptom Diseases 0.000 claims description 6
- 210000001635 urinary tract Anatomy 0.000 claims description 5
- 244000298479 Cichorium intybus Species 0.000 claims description 4
- 208000002720 Malnutrition Diseases 0.000 claims description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 201000002451 Overnutrition Diseases 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 235000020823 overnutrition Nutrition 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 3
- 235000000112 undernutrition Nutrition 0.000 claims description 2
- KGOLAIOCIQYQQY-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2,3-dihydroxybutanedioic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)C(O)C(O)C(O)=O KGOLAIOCIQYQQY-JEDNCBNOSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 16
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract description 3
- 229960002442 glucosamine Drugs 0.000 abstract description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 3
- 229920002567 Chondroitin Polymers 0.000 abstract description 2
- 241000186660 Lactobacillus Species 0.000 abstract description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 abstract description 2
- 229940039696 lactobacillus Drugs 0.000 abstract description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract description 2
- 239000006014 omega-3 oil Substances 0.000 abstract description 2
- 230000002485 urinary effect Effects 0.000 abstract description 2
- 241000723343 Cichorium Species 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 23
- 229960003284 iron Drugs 0.000 description 21
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 17
- 235000010755 mineral Nutrition 0.000 description 16
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 15
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 14
- 241000282472 Canis lupus familiaris Species 0.000 description 11
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 9
- 239000004365 Protease Substances 0.000 description 7
- 206010003246 arthritis Diseases 0.000 description 7
- 235000004251 balanced diet Nutrition 0.000 description 7
- 229960002173 citrulline Drugs 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 241000282465 Canis Species 0.000 description 5
- -1 L-Carnitine L-Tartrate L-Lysine Chemical compound 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940049920 malate Drugs 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 3
- 241000282324 Felis Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- 230000005802 health problem Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000026723 Urinary tract disease Diseases 0.000 description 2
- 208000012931 Urologic disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000000555 dodecyl gallate Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 230000005804 musculo-skeletal problem Effects 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229940096730 pancreatin 4x Drugs 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 208000024335 physical disease Diseases 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000014001 urinary system disease Diseases 0.000 description 2
- 230000037221 weight management Effects 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241001408630 Chloroclystis Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- GFBKORZTTCHDGY-UWVJOHFNSA-N Thiothixene Chemical compound C12=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C2\C1=C\CCN1CCN(C)CC1 GFBKORZTTCHDGY-UWVJOHFNSA-N 0.000 description 1
- 208000006593 Urologic Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- HOPSCVCBEOCPJZ-UHFFFAOYSA-N carboxymethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)=O HOPSCVCBEOCPJZ-UHFFFAOYSA-N 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000007089 exocrine pancreatic insufficiency Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960002358 iodine Drugs 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000021413 well-balanced diet Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Abstract
A composition or dietary supplement for a pet is provided. The composition comprises: a supplement for joint health, such as glucosamine, methylsulfonlymethane, chondroitin, pine bark extract, or omega 3 fatty acids; a supplement for digestive health such as digestive enzymes; a probiotic such as Lactobacillus spp. or Enterococcus faecium; a prebiotic such as fibre or chicory extract; at least one vitamin and at least one mineral. The composition may also comprise cardiovascular health supplements such as L-arginine; weight loss supplements such as L-carnitine L-tartrate; energy supplements such as L-citrulline DL-malate; urinary or kidney tract health supplements such as taurine; liver health supplements such as milk thistle; and bone health supplements such as calcium. Also described are methods of treatment using the composition.
Description
(71) Applicant(s):
Dr Glenson's pet nutrition
Castletown, Kilberry, Navan, County Meath, Ireland
1602804.5 (51) INT CL:
A61K 31/737 (2006.01)
17.02.2016 A23K 20/00 (2016.01)
A23K 20/189 (2016.01)
- A23K 50/40 (2016.01)
A61K 31/205 (2006.01) A61K 33/06 (2006.01) A61K 36/28 (2006.01)
A23K 10/18 (2016.01) A23K 20/174 (2016.01) A23K 20/20 (2016.01) A61K 31/198 (2006.01) A61K 31/726 (2006.01) A61K 36/00 (2006.01) A61K 38/46 (2006.01) (72) Inventor(s):
Robert Early (74) Agent and/or Address for Service:
Tomkins & Co
Dartmouth Road, Dublin 6 DO6 F9C7, Ireland (56) Documents Cited:
CN 104256206 A US 20130216521 A1
US 6156355 A1 US 20080260708 A1
Wholistic Canine Complete Joint Mobility, The Wholistic Pet, 14 May 2015. Available online at https:// web.archive.org/web/20150514235421/http:// www.thewholisticpet.com/wholistic-canine-completejoint-mobilitytm.html [Accessed 27 October 2016] Wholistic Canine Complete, The Wholistic Pet, 11 March 2015. Available online at https:// web.archive.org/web/20150311225006/http:// www.thewholisticpet.com/canine-product-line/healthcare-supplements/wholistic-canine-completetm.html [Accessed 27 October 2016]
The Wholistic Pet Health Care Supplements, The Wholistic Pet, 17 March 2015. Available online at https://web.archive.Org/web/20150317073342/http:// www.thewholisticpet.com/canine-product-line/healthcare-supplements.html [Accessed 27 October 2016] (58) Field of Search:
Other: WPI, EPODOC, INTERNET (54) Title of the Invention: Dietary supplement
Abstract Title: Complete dietary supplements for pets (57) A composition or dietary supplement for a pet is provided. The composition comprises: a supplement for joint health, such as glucosamine, methylsulfonlymethane, chondroitin, pine bark extract, or omega 3 fatty acids; a supplement for digestive health such as digestive enzymes; a probiotic such as Lactobacillus spp. or Enterococcus faecium; a prebiotic such as fibre or chicory extract; at least one vitamin and at least one mineral. The composition may also comprise cardiovascular health supplements such as L-arginine; weight loss supplements such as Lcarnitine L-tartrate; energy supplements such as L-citrulline DL-malate; urinary or kidney tract health supplements such as taurine; liver health supplements such as milk thistle; and bone health supplements such as calcium. Also described are methods of treatment using the composition.
1/3
FIGURE 1
Nutritional Ingredients | Per 100 g | Per Sachet |
L-Arginine | 12.31 g | 1.00 g |
L-Citrulline DI Malate | 3.08 g | 0.25 g |
L-Glutamine | 36.92 g | 3.00 g |
L-Carnitine L-Tartrate | 2.47 g | 0.20 g |
L-Lysine | 3.08 g | 0.25 g |
Glucosamine Sulphate 2KCL | 6.16 g | 0.50 g |
Methyl-Sulfonyl-Methane (MSM) | 6.16 g | 0.50 g |
Chondroitin Sulphate (Bovine) | 2.47 g | 0.20 g |
Pine Bark Extract | 0.25 g | 0.02 g |
Flax Seed Oil Powder | 12.31 g | 1.00 g |
Omega 3 DHA Powder | 1.85 g | 0.15 g |
Milk Thistle (Silybum Marianum) | 1.24 g | 0.10 g |
Digestive Enzymes | 0.93 g | 0.08 g |
Prebiotics | 1.24 g | 0.10 g |
Probiotics | 0.87 g | 0.07 g |
Vitamins & Minerals | Per 100 | g | Per Sachet |
Vitamin A | 4.66 | mg | 0.379 mg |
Vitamin D | 41.84 | ug | 3.400 ug |
Vitamin E | 98.44 | mg | 8.000 mg |
Vitamin K | 307.62 | ug | 25.000 ug |
Vitamin B1 | 6.89 | mg | 0.560 mg |
Vitamin B2 | 16.00 | mg | 1.300 mg |
Vitamin B3 | 49.22 | mg | 4.000 mg |
2/3
Vitamin E36 | 4.92 | mg | 0.400 | mg |
Vitamin E39 (Folic Acid) | 836.72 | ug | 68.000 | ug |
Vitamin E312 | 110.74 | ug | 9.000 | ug |
Vitamin E35 | 49.22 | mg | 4.000 | mg |
Iron | 92.28 | mg | 7.500 | mg |
Zinc | 184.57 | mg | 15.000 | mg |
Copper | 18.46 | mg | 1.500 | mg |
Selenium | 1107.42 | ug | 90.000 | ug |
Iodine | 2707.03 | ug | 220.000 | ug |
Sodium | 2657.81 | mg | 216.000 | mg |
FIGURE 2
Nutritional Ingredients | Per 100 | g | Per Sachet | |
L-Arginine | 12.31 | g | 1.00 | g |
L-Citrulline DI Malate | 3.08 | g | 0.25 | g |
L-Glutamine | 36.92 | g | 3.00 | g |
L-Carnitine L-Tartrate | 2.47 | g | 0.20 | g |
L-Lysine | 3.08 | g | 0.25 | g |
Glucosamine Sulphate 2KCL | 6.16 | g | 0.50 | g |
Methyl-Sulfonyl-Methane (MSM) | 6.16 | g | 0.50 | g |
Chondroitin Sulphate (Bovine) | 2.47 | g | 0.20 | g |
Pine Bark Extract | 0.25 | g | 0.02 | g |
Flax Seed Oil Powder | 12.31 | g | 1.00 | g |
Omega 3 DHA Powder | 1.85 | g | 0.15 | g |
Milk Thistle (Silybum Marianum) | 1.24 | g | 0.10 | g |
Digestive Enzymes | 0.93 | g | 0.08 | g |
3/3
Prebiotics | 1.24 | g | 0.10 | g |
Probiotics | 0.87 | g | 0.07 | g |
Omega 6 | 0.86 | g | ||
Calcium | 7.88 | mg | ||
Taurine | 3.69 | g |
Vitamins & Minerals | Per 100 | g | Per Sachet | |
Vitamin A | 4.66 | mg | 0.379 | mg |
Vitamin D | 41.84 | ug | 3.400 | ug |
Vitamin E | 98.44 | mg | 8.000 | mg |
Vitamin K | 307.62 | ug | 25.000 | ug |
Vitamin E31 | 6.89 | mg | 0.560 | mg |
Vitamin E32 | 16.00 | mg | 1.300 | mg |
Vitamin E33 | 49.22 | mg | 4.000 | mg |
Vitamin E36 | 4.92 | mg | 0.400 | mg |
Vitamin E39 (Folic Acid) | 836.72 | ug | 68.000 | ug |
Vitamin E312 | 110.74 | ug | 9.000 | ug |
Vitamin E35 | 49.22 | mg | 4.000 | mg |
Iron | 92.28 | mg | 7.500 | mg |
Zinc | 184.57 | mg | 15.000 | mg |
Copper | 18.46 | mg | 1.500 | mg |
Selenium | 1107.42 | ug | 90.000 | ug |
Iodine | 2707.03 | ug | 220.000 | ug |
Sodium | 2657.81 | mg | 216.000 | mg |
Title
Dietary Supplement
Field of the Invention
The current invention relates to a dietary supplement for animals or pets. In particular, the current invention relates to a supplement for effectively preventing and/or treating common diseases in an animal or pet. The invention also relates to a supplement for providing a balanced diet in an animal or pet.
Background to the Invention
The field of veterinary supplementation is small but rapidly growing. Unfortunately, in recent years, there has been an increase in the occurrence of underlying health conditions in household pets, such as canines and felines. Pets often suffer as a result of curable diseases that their owners simply do not have the necessary resources to prevent or to treat. There are various factors which may be contributing to this surge, such as overbreeding, poor quality pet food and malnutrition.
Overbreeding and selective breeding can lead to a range of health problems in pets. For hundreds of years dogs have been cross-bread to produce new breeds, e.g. “toy dogs”. When two dogs are cross-bread to make a new breed, health problems can arise as a result. For example, pugs are known to suffer from bad ear infections and larger dogs, such as wolfhounds, tend to suffer from joint problems or heart problems.
A rise in the use of bagged pet food products has decreased the quality of some generic brands due to supply and demand pressures and the burden of mass production. Furthermore, many pet food products on the current market do not contain a sufficient amount of the essential nutrients that a pet requires and are often rich in crude proteins, which have a very low biological value.
A balanced diet is of vital importance for maintaining good health. It is an unfortunate reality that some pets are often mistreated and may be undernourished as a result. Over-nutrition is also a form of malnutrition which can be detrimental to a pet’s health. Over consumption of calories can lead to obesity in pets, which when combined with a lack of daily exercise, can increase the risk of developing disorders including diabetes, hypertension, cancer, musculoskeletal problems, cardiovascular disease and arthritis.
Thus it is clear that many pets are not receiving the correct type and/or amount of nutrients in their daily diet and are at risk of developing a number of diseases or conditions as a result. Commercial pet foods are simply not formulated with a specific treatment in mind. Furthermore, there are no dietary supplements for pets on the market that contain a sufficient amount of the vitamins and minerals required to provide a balanced diet whilst also preventing and/or treating disease. In addition, many pet owners find it difficult to administer a dietary supplement to a pet and pets are often reluctant to take tablets or pills. Perseverance can be stressful for both the pet and the owner with many owners choosing to omit a pet supplement from their pet’s diet as a result.
The current invention serves to alleviate these problems by providing a supplement for effectively preventing, treating and/or alleviating common diseases in animals or pets. The current invention provides a daily serving of the essential nutrients that a pet requires and that is not provided by their normal diet of dry or wet pet food. The supplement is provided in a manner that is easy to administer to a pet.
Summary of the Invention
A first aspect of the invention provides a composition or supplement comprising an effective amount of at least one supplement for joint health, at least one supplement for digestive system health, at least one probiotic, at least one prebiotic, at least one vitamin and at least one mineral. The composition is for the prevention, alleviation and/or treatment of a disease or condition in an animal or pet. The composition is for maintenance of good health in a pet.
Preferably, said at least one vitamin is one or more selected from the group comprising vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12 and vitamin B5.
Preferably, said at least one mineral is one or more selected from the group comprising iron, zinc, copper, selenium, iodine and sodium.
Typically, said at least one probiotic is selected from the group comprising
Bifidobacterium lactis, Bifidobacterium animalis, Lactobacillus acidophilus,
Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus casei, Lactobacillus plantarum and Enterococcus faecium.
Preferably, said at least one probiotic is Enterococcus faecium.
Preferably, said at least one supplement for joint health is one or more selected from the group comprising glucosamine sulphate, Methyl-Sulfonyl-Methane (MSM), chondroitin sulphate, pine bark extract, flax seed oil powder, omega 3 DHA powder, Lgiutamine, L-lysine, Omega 6. Preferably, said at least one supplement for joint health is one or more selected from the group comprising glucosamine sulphate, MethylSulfonyl-Methane (MSM), chondroitin sulphate, pine bark extract, flax seed oil powder, omega 3 DHA powder, L-glutamine and L-lysine.
Preferably, said at least one supplement for digestive system health is a digestive enzyme. Preferably, the at least one supplement may also be a probiotic and or a prebiotic. Typically, said digestive enzyme is one or more selected from the group comprising protease, amylase, lipase and cellulase.
The vitamin may be present in an amount of from about 0.05 w/w % to about 10 w/w %, preferably about 0.1 w/w% to about 5 w/w %, preferably about 0.15 w/w % to 1 w/w %, preferably about 0.23 w/w% relative to the total weight of the composition on a dry solids basis.
The mineral may be present in an amount of from about 0.01 w/w % to about 10.0 w/w % preferably about 0.05 w/w % to 5 w/w %, preferably about 0.10 w/w % to 4 w/w%, preferably 2.9%, relative to the total weight of the composition on a dry solids basis.
The supplement for joint health may be present in an amount of from about 0.2 w/w % to about 85.0 w/w % preferably about 10.0 w/w % to about 80.0 w/w %, preferably 67.0 w/w% to 82 w/w % relative to the total weight of the composition on a dry solids basis.
The at least one supplement for digestive health may be present in an amount of from about 0.05 w/w% to about 20 w/w % preferably about 0.5 to about 10 w/w %, preferably about 0.70 to about 5 w/w %, preferably about 2 w/w % relative to the total weight of the composition on a dry solids basis.
The probiotic may be present in an amount of from about 0.10 w/w% to about 5 w/w%, preferably about 0.60 w/w% to 2 w/w%, preferably, 0.87 w/w% relative to the total weight of the composition on a dry solids basis.
The prebiotic may be present in an amount of from about 0.5 w/w% to about 10 w/w%, preferably about 1 to 3 w/w%, preferably about 2.5 w/w%, preferably, about 1.24 w/w% relative to the total weight of the composition on a dry solids basis.
Preferably, said composition further comprises at least one supplement for cardiovascular health. Typically, said supplement is L-arginine. The at least one supplement for cardiovascular health may be present in an amount of from about 0.5 w/w% to about 50 w/w%, preferably about 1.0 to about 40 w/w%, preferably about 5 w/w% to about 30 w/w% preferably, about 12 w/w% relative to the total weight of the composition on a dry solids basis.
Preferably, the composition further comprises at least one supplement for weight loss and/or for treating or preventing obesity. Typically, said supplement may be present in an amount of from about 0.5 w/w% to about 20 w/w %, preferably about 1 w/w% to about 10 w/w%, preferably about 2.5 w/w% to about 3 w/w % relative to the total weight of the composition on a dry solids basis.. Typically, said supplement is L-carnitine Ltartrate.
Preferably, the composition further comprises at least one supplement for liver health. Typically, said supplement may be present in an amount of from about 0.05 w/w% to about 20 w/w %, preferably about 0.5 w/w% to about 5 w/w%, preferably about 1.25 w/w % relative to the total weight of the composition on a dry solids basis. Typically, said supplement is milk thistle. The supplement may be L-carnitine L-tartrate.
Preferably, the composition further comprises at least one supplement for energy. Preferably, said supplement is L-citrulline DL-malate. Typically, said supplement may be present in an amount of from about 0.05 w/w% to about 20 w/w %, preferably about 0.5 w/w% to about 5 w/w%, preferably about 3 w/w % relative to the total weight of the composition on a dry solids basis..
Preferably, the composition further comprises at least one supplement for bone health. Typically, said supplement is calcium. Typically, said supplement may be present in an amount of from about .001 w/w% to about 5 w/w%, preferably, about .005 w/w% to about 2 w/w%, preferably .007 w/w % relative to the total weight of the composition on a dry solids basis.
Preferably, the composition further comprises at least one supplement for kidney health or urinary tract health. Typically, said supplement is taurine. Typically, said supplement may be present in an amount of from about 0.5 w/w% to about 10 w/w%, preferably, about 1.0 w/w% to about 5.0 w/w%, preferably 3.7 w/w % relative to the total weight of the composition on a dry solids basis.
In one embodiment said composition comprises vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DLMalate, L-Glutamine, L-Carnitine L-Tartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder, Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics.
In one embodiment said composition comprises vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DLMalate, L-Glutamine, L-Carnitine L-Tartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder, Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics, calcium, omega 6 and taurine.
Preferably, the composition is in the form of a dry powder. Preferably, said dry powder is suitable for addition to a food product.
Preferably, the composition is in the form of granules.
Typically, the composition is in power form in a sachet or capsule.
Alternatively, said composition is in liquid form. Preferably, said composition is in a sachet or capsule.
Conveniently, the composition is administered in a dose of once per day. Preferably, the composition is for oral administration to a pet once per day. Typically, said administration is at any time of day. Preferably, said administration is in the morning. Alternatively, said administration is in the evening.
In one embodiment, the composition further comprises a bulking agent, a sweetener and/or a filler.
Preferably, said composition is a food product.
The current invention also provides a method of prevention and/or treatment of a disease or condition in a pet by feeding to said pet a composition or supplement according to the present invention and as described above.
The current invention also provides a method of alleviating the symptoms of a disease or condition in a pet by feeding or administering to said pet a composition or supplement according to the present invention and as described above.
The current invention also provides a method of providing a balanced diet to a pet. The method comprises administering or feeding to said animal a composition or supplement according to the present invention and as described above.
The current invention also provides a method of maintaining good health in a pet. The method comprises administering or feeding to said animal a composition or supplement according to the present invention and as described above.
Preferably said method or methods of the invention comprise a step of administering said composition to a pet. Typically, said composition is administered to a food product to be ingested by said pet. Conveniently, the supplement is administered in a dose of once per day.
A further aspect of the invention provides a supplement or composition according to the present invention and as described above for use to treat or prevent a disease or condition in a pet.
A further aspect of the invention provides a supplement or composition according to the present invention and as described above for use to provide a balanced diet.
Preferably, said disease or condition is selected from the group comprising a joint condition, a digestive system condition, a cardiovascular condition, a condition associated with under or over nutrition, obesity, diabetes, urinary tract disease and cancer.
Typically, said joint condition is a degenerative joint condition or osteoarthritis. Preferably, said joint condition is arthritis, a result of an injury or an infection to a joint, a congenital disorder or cancer.
Preferably, said digestive system condition is any condition that affects the stomach and intestines resulting in pain. Said digestive system condition may be selected from the group comprising acute gastroenteritis, colitis, constipation, diarrhea, pancreatitis, small intestinal malabsorption, and exocrine pancreatic insufficiency.
Preferably, said cardiovascular condition may be congenital or acquired. Said condition may be cardiomyopathy.
Preferably, said condition is a compromised immune system.
Preferably, said disease or condition is a liver disease or condition.
Preferably, said condition is obesity or a condition associated with obesity, typically diabetes, hypertension, cancer, musculoskeletal problems, cardiovascular disease and arthritis.
Preferably, said animal or pet may be a canine or dog, a feline or cat, a bird, a horse, a rabbit, a rodent, a fish, a turtle or a guinea pig.
In one embodiment, the composition comprises the following:
Nutritional Ingredients | Per 100 g | Per Sachet |
L-Arginine | 12.31 g | 1.00 g |
L-Citrulline DI Malate | 3.08 g | 0.25 g |
L-Glutamine | 36.92 g | 3.00 g |
L-Carnitine L-Tartrate | 2.47 g | 0.20 g |
L-Lysine | 3.08 g | 0.25 g |
Glucosamine Sulphate 2KCL | 6.16 g | 0.50 g |
Methyl-Sulfonyl-Methane (MSM) | 6.16 g | 0.50 g |
Chondroitin Sulphate (Bovine) | 2.47 g | 0.20 g |
Pine Bark Extract | 0.25 g | 0.02 g |
Flax Seed Oil Powder | 12.31 g | 1.00 g |
Omega 3 DHA Powder | 1.85 g | 0.15 g |
Milk Thistle (Silybum Marianum) | 1.24 g | 0.10 g |
Digestive Enzymes | 0.93 g | 0.08 g |
Prebiotics | 1.24 g | 0.10 g |
Probiotics | 0.87 g | 0.07 g |
Vitamins & Minerals | Per 100 | g | Per Sachet |
Vitamin A | 4.66 | mg | 0.379 mg |
Vitamin D | 41.84 | ug | 3.400 ug |
Vitamin E | 98.44 | mg | 8.000 mg |
Vitamin K | 307.62 | ug | 25.000 ug |
Vitamin B1 | 6.89 | mg | 0.560 mg |
Vitamin B2 | 16.00 | mg | 1.300 mg |
Vitamin B3 | 49.22 | mg | 4.000 mg |
Vitamin B6 | 4.92 | mg | 0.400 mg |
Vitamin B9 (Folic Acid) | 836.72 | ug | 68.000 ug |
Vitamin B12 | 110.74 | ug | 9.000 ug |
Vitamin B5 | 49.22 | mg | 4.000 mg |
Iron | 92.28 | mg | 7.500 mg |
Zinc | 184.57 | mg | 15.000 mg |
Copper | 18.46 | mg | 1.500 mg |
Selenium | 1107.42 | ug | 90.000 ug |
Iodine | 2707.03 | ug | 220.000 ug |
Sodium | 2657.81 | mg | 216.000 mg |
Table 1: Composition of an embodiment of the invention.
Preferably, said composition is suitable for administration to a dog.
In one embodiment, the composition comprises the following:
Nutritional Ingredients | Per 100 | g | Per Sachet | |
L-Arginine | 12.31 | g | 1.00 | g |
L-CitruNine DI Malate | 3.08 | g | 0.25 | g |
L-Glutamine | 36.92 | g | 3.00 | g |
L-Carnitine L-Tartrate | 2.47 | g | 0.20 | g |
L-Lysine | 3.08 | g | 0.25 | g |
Glucosamine Sulphate 2KCL | 6.16 | g | 0.50 | g |
Methyl-Sulfonyl-Methane (MSM) | 6.16 | g | 0.50 | g |
Chondroitin Sulphate (Bovine) | 2.47 | g | 0.20 | g |
Pine Bark Extract | 0.25 | g | 0.02 | g |
Flax Seed Oil Powder | 12.31 | g | 1.00 | g |
Omega 3 DHA Powder | 1.85 | g | 0.15 | g |
Milk Thistle (Silybum Marianum) | 1.24 | g | 0.10 | g |
Digestive Enzymes | 0.93 | g | 0.08 | g |
Prebiotics | 1.24 | g | 0.10 | g |
Probiotics | 0.87 | g | 0.07 | g |
Omega 6 | 0.86 | g | ||
Calcium | 7.88 | mg | ||
Taurine | 3.69 | g |
Vitamins & Minerals | Per 100 | g | Per Sachet | |
Vitamin A | 4.66 | mg | 0.379 | mg |
Vitamin D | 41.84 | ug | 3.400 | ug |
Vitamin E | 98.44 | mg | 8.000 | mg |
Vitamin K | 307.62 | ug | 25.000 | ug |
Vitamin B1 | 6.89 | mg | 0.560 | mg |
Vitamin B2 | 16.00 | mg | 1.300 | mg |
Vitamin B3 | 49.22 | mg | 4.000 | mg |
Vitamin B6 | 4.92 | mg | 0.400 | mg |
Vitamin B9 (Folic Acid) | 836.72 | ug | 68.000 | ug |
Vitamin B12 | 110.74 | ug | 9.000 | ug |
Vitamin B5 | 49.22 | mg | 4.000 | mg |
Iron | 92.28 | mg | 7.500 | mg |
Zinc | 184.57 | mg | 15.000 | mg |
Copper | 18.46 | mg | 1.500 | mg |
Selenium | 1107.42 | ug | 90.000 | ug |
Iodine | 2707.03 | ug | 220.000 | ug |
Sodium | 2657.81 | mg | 216.000 | mg |
Preferably, said composition is suitable for administration to a cat.
The term “pet” when used herein refers to a domestic or tamed animal or bird kept for companionship or pleasure. The terms “animal” and “pet” may be used interchangeably.
The term an “effective amount” when used herein is the amount of a supplement or ingredient that is sufficient to achieve the desired effect.
The term “supplement” when used herein is a product or ingredient added to a composition in order to complete it or enhance it. It may be used interchangeably herein with component or composition.
Brief Description of the Drawings
Figure 1 is an embodiment of a preferred composition of the invention.
Figure 2 is an embodiment of a preferred composition of the invention.
Detailed Description
The normal daily diet of animals and pets, such as canines and felines, often lacks a sufficient amount of the necessary nutrients required to maintain a balanced diet. This can increase the risk and occurrence of disease and underlying health conditions. The current invention provides a daily serving of essential vitamins and minerals combined with additional health boasting ingredients, which together, serve to effectively prevent, treat and/or alleviate common diseases and conditions in animals and pets.
In general terms, the composition of the invention comprises at least one supplement for joint health, at least one supplement for digestive health, at least one vitamin, at least one probiotic, at least one prebiotic and at least one mineral. It will be appreciate that the components of the composition may also have additional benefits than those stated.
When used as part of the daily diet of an animal or pet, the composition of the invention can be used to treat or alleviate the symptoms of one or more diseases or conditions. The disease or condition may be a joint condition. The disease or condition may be a digestive condition. The disease or condition may be a cardiovascular condition. The disease or condition may be obesity. The disease or condition may be a liver condition. The disease or condition may also be a urinary tract disease or kidney disease. The disease or condition may be a bone disease. The composition of the invention may also provide an energy boost.
The composition of the invention may be part of the daily diet of an animal or pet. It may be added to the pet’s usual pet food, preferably as a powder. By administering the composition in this manner, the pet does not realise that it has been included in the pet food and will ingest it at the same time as the pet food thereby allowing ease of administration. It will be appreciated that it can be administered any time of the day or night. Preferably, the composition is administered in the morning. The composition is for administration once a day.
In an embodiment of the invention, the supplement or composition of the invention may comprise at least one supplement for joint health. Animals can often suffer from degenerative joint conditions or osteoarthritis. Arthritis, in dogs is one of the most common health problems encountered by veterinarians. Early warning signs often go unnoticed as dogs will often ignore the soreness until the condition has progressed quite significantly at which point the dog will be in significant pain. Other joint conditions may be the result of an injury or an infection to a joint, a congenital disorder or cancer. Without being bound by theory, administering the composition according to the present invention to a pet or animal may also result in improved bone health, increased bone formation and reduces bone loss, which can be associated with age in animals. This provides better mobility in animals.
The at least one supplement for joint health may be from one to ten supplements, preferably from one and six supplements, including two, three, four and five supplements. The supplement for joint health of the present invention may be one or more of glucosamine sulphate, Methyl-Sulfonyl-Methane (MSM), chondroitin sulphate, pine bark extract, flax seed oil powder, omega 3 DHA powder, L-glutamine and Llysine. The supplement for joint health my be one or more of glucosamine sulphate, Methyl-Sulfonyl-Methane (MSM), chondroitin sulphate, pine bark extract, flax seed oil powder, omega 3 DHA powder, L-glutamine, L-Sysine, calcium, omega 6 and taurine. It will be appreciated that the composition may comprise all or any of the listed supplements. The amount present may be any amount that is an effective amount of same supplement. The supplements may be salts.
The supplement for joint health of the present invention may be glucosamine sulphate. Without being bound by theory, glucosamine sulphate may aids the smooth working of the joints. It can also help to maintain connective tissues. The supplement for joint health may be MSM. MSM can alleviate the pain or discomfort caused by arthritis or back pain by working as an anti-inflammatory. MSM is also considered to be a potentiator of vitamins, such as vitamin C, A, D and E, selenium by improving the uptake of these nutrients and prolongs their duration. It has also been suggested that MSM can provide protection against the onset of cancer and may improve glucose uptake thus balancing blood sugar levels and aiding normal functioning of the pancreas. The supplement for joint health may be chondroitin sulphate. This supplement acts to treat or alleviate the symptoms of osteoarthritis that results from breakdown of joint cartilage and underlying bone. The supplement for joint health may be pine bark extract. Pine bark extract can help to treat arthritis by combating inflammation. It may also improve circulation. The supplement for joint health may be flaxseed oil, preferably flaxseed oil powder. Flaxseed oil comprises alpha-linoleic fatty acid and can lubricate joints and lessens joint pain. Flaxseed is also thought to provide a softer and shinier coat and to also protect the skin beneath the coat. The supplement for joint health may be omega 3, preferably omega 3 DHA (docosahexanoic acid) powder. The supplement for joint health may be omega 6. Omega 3 and omega 6 are polyunsaturated fatty acids (PUFAs) and have joint health benefits and may be used to treat arthritis. Without the necessary levels of omega-3 and 6 fatty acids animals may suffer from dry, flaky skin which may lead to hair loss and excessive shedding. The source of omega 3 may be flaxseed oil.
The supplement for joint health may be present in an amount of from about 0.2 w/w % to about 85 w/w % preferably about 10 w/w % to about 82%, preferably, about 40 w/w % to about 82%, preferably, 40, 45, 50, 55, 60, 65, 70, 75, 80, w/w%. Preferably 67 % to 82 w/w %, preferably 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82 w/w% relative to the total weight of the composition on a dry solids basis.
The one or more supplement for joint health is present in an amount of between about 0.1g to about 85 g per 100g of composition. Preferably, about 1g to about 70g, preferably about 20 to 50g, preferably 30g.
The one or more supplement for joint health may be glucosamine sulphate or glucosamine sulphate 2KCL. Glucosamine sulphate may be present in an amount of from about 1 g to about 10 g per 100 g of the composition. Preferably, the range is from about 2 g to about 8 g, preferably 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, or 8 g. In a preferred embodiment, 100 g of the composition comprises from 6g to 7 g of glucosamine, for example, 6.16 g.
If the one or more supplement for joint health is methyl-sulfonyl-methane (MSM), in one embodiment MSM is present in an amount of from about 1 g to about 10 g per 100 g of the composition, preferably 1, 1.5, 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, or 10 g. Preferably, the range is from about 2.0g to about 8.0g, preferably, about 6 g. In a preferred embodiment, 100 g of the composition comprises from about 6 to about 7 g of MSM, for example, about 6.16 g.
If the one or more supplement for joint health is chondroitin sulphate (Bovine), in one embodiment chondroitin sulphate is present in an amount of from about 1g to about 10.Og per 100g of the composition, preferably 1, 1.5, 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6, 6.5, 7,
7.5, 8, 8.5, 9, 9.5 or 10g. Preferably, the range is from about 1g to about 5g, preferably, about 2g. In a preferred embodiment, 100g of the composition comprises from about 2 g to about 2.5 g of chondroitin sulphate, for example, 2.47g.
If the one or more supplement for joint health is pine bark extract, in one embodiment pine bark extract is present in an amount of from 0.05g to about 5g per 100g of the composition, preferably 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1.0, 1.5, 2, 2.5, 3, 3.5, 4.5 or 5 g. Preferably, the range is from about 0.1 g to about 2 g, preferably, about 0.2 g. In a preferred embodiment, 100 g of the composition comprises pine bark extract from 0.2 to 0.3g, for example, 0.25 g.
Preferably, said l-glutamine is present in an amount of from about 1 g to about 50 g per 100g. Preferably, about 20 g to about 40 g, preferably 20, 20.5, 21, 21.5, 22, 22.5, 23,
23.5, 24, 24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30, 30.5, 31, 31.5, 32,
32.5, 33, 33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39, 39.5 or 40g preferably, about 37g. Still preferred, said l-glutamine is present in an amount of about 36.92 g per 100g of composition.
If the one or more supplement for joint health is flaxseed oil, said flax seed oil is present in an amount of from about 1 g to about 50 g per 100 g of composition. Preferably, about 5g to about 20g, typically about 5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10, 10.5, 11, 11.5, 12, 12.5, 13,13.5, 14,14.5, 15,15.5,16,16.5,17,17.5,18 18.5, 19, 19.5 or 20g. Preferably, about 12 g. Still preferred, said flax seed oil is present in an amount of about 12.31 g per 100 g of composition.
If the one or more supplement for joint health is omega 3, preferably omega 3 DHA powder, omega 3 is present in an amount of from about 0.5 g to about 10 g per 100g of composition, preferably 0.5, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, or 10 g. Preferably, about 1 g to about 3 g, preferably, about 2 g. Still preferred, said omega 3 is present in an amount of about 1.85 g per 100 g of composition. The source of omega 3 may be flaxseed oil powder.
If the one or more supplement for joint health is omega 6, omega 6 is present in an amount of from about 0.5 g to about 5 g per 100 g, preferably 0.5, 1.0, 1.5, 2, 2.5, 3,
3.5, 4, 4.5 or 5 g. Preferably, about 1 g to about 3 g, preferably, about 1 g. Still preferred, said omega 6 DHA powder is present in an amount of about 0.86 g per 100 g of composition.
If the one or more supplement for joint health is L-lysine, L-lysine is present in an amount of from about 0.5g to about 10g per 100g, preferably 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10 g. Preferably, about 1g to about 5g, preferably, about 3g. Still preferred, said L-lysine is present in an amount of about 3.08 mg per 100g of composition.
The supplement or composition may comprise at least one supplement for digestive health. Diseases that affect the gastrointestinal tract, including the stomach, are common in pets. A short digestive tract and poor quality pet food are two contributing factors. These disease include those caused by an infection with a bacteria or a virus and conditions such as tumours or obstruction. Healthy digestion is essential for a pet to be able to use the nutrients from food to build and repair tissues and obtain energy.
The at least one supplement may be from one to ten supplements, preferably from one and four supplements, including two or three supplements. The supplement for digestive health of the present invention may be a digestive enzyme. It will be appreciated that the composition may comprise all or any of the listed supplements. The amount present may be any amount that is an effective amount of same supplement.
The at least one supplement for digestive health may be present in an amount of from about 0.05 w/w% to about 20 w/w % preferably about 0.5 to about 10 w/w %, preferably about 0.5 to about 5 w/w %, preferably 0.5, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5 or 5 w/w %, preferably 2 w/w % relative to the total weight of the composition on a dry solids basis.
Preferably, said supplement for digestive health is present in an amount of from about 0.05 g to about 10 g per 100 g, preferably about 0.5g to about 3g, preferably, about 1.0 gThe supplement for digestive health may be one or more digestive enzymes. Digestive enzymes are enzymes that are primarily produced in the pancreas and the small intestine and function to break polymeric macromolecules into smaller blocks in order to facilitate their absorption by the body. The digestive enzyme may be protease, amylase, lipase and or cellulase. Protease functions to break down and digest protein. Amylase breaks down carbohydrate. Lipase breaks down fat and cellulase breaks down fibre.
In the composition the digestive enzymes may be one of more selected from the group comprising Betaine HCL (or Betain HCL), Bromelain, Pancreatin 4X -containing Protease; containing Amylase; containing Lipase.
Preferably, the digestive enzymes may comprise one or more of the following
- Betaine HCL (or Betain HCL)
- Bromelain 1200 GDU/g
- Pancreatin 4X
Containing Protease - NLT 4.0 x USP (100 USP units/mg)
Containing Amylase - NLT 4.0 x USP (100 USP units/mg)
Containing Lipase - NLT 8.0 x USP (100 USP units/mg)
The supplement for digestive health may be a probiotic. The supplement for digestive health may be a prebiotic.
Preferably, said digestive enzymes are present in an amount of from about 0.05g to about 10g per 100g, preferably 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7,
7.5, 8, 8.5, 9, 9.5 or 10 g. Preferably, about 0.5g to about 3g, preferably, about 1 g. Still preferred, said digestive enzymes is present in an amount of about 0.93 g per 100 g of composition.
It is advantageous for the supplement or composition to further comprise at least one supplement for liver health. In one embodiment, the supplement for liver health may be milk thistle (Silybum Marianum). Milk thistle may also be used to treat liver disease and may protect the liver against toxins, such as drugs, and stimulate new liver cells and protein synthesis. It is also thought to be an antioxidant and an anti-inflammatory agent. It may also be useful to aid healing after drug therapy.
Preferably, said at least one supplement for liver health, preferably milk thistle (silybum marianum) is present in an amount of from about 0.5g to about 10g per 100g, preferably 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1.0, 1.5, 2, 2.5, 3, 3.5, 4,
4.5, 5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10g. Preferably, about 1g to about 3g, preferably, about 1g. Still preferred, said omega 3 DHA powder is present in an amount of about 1.24 g per 10Og of composition.
The supplement or composition may comprise at least one supplement for energy. In one embodiment, the supplement for energy may be L-Citrulline DL-Malate. It will be appreciated that L-Citrulline DL-Malate may also play a role in digestive health. Preferably, said at least one supplement for energy, preferably L-Citrulline DL-Malate, is present in an amount of from about 0.5g to about 10g per 100g, preferably 0.5, 1,
1.5, 2, 2.5, 3, 3.5, 4, 4.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10g. Preferably, about 1g to about 5g, preferably, about 3g. Still preferred, said L-Citrulline DL-Malate is present in an amount of about 3.08 mg per 100g of composition.
The supplement or composition may comprise at least one probiotic. There may be one to five probiotics included, preferably, two, three or four. There Probiotics are live bacteria that are good for overall gastrointestinal maintenance and health. Many pet foods do not contain probiotics, as probiotics are sensitive to moisture and heat and are thus unlikely to survive the manufacturing process. Probiotics can treat diarrhoea and alleviate digestive system upset. Probiotics can also aid recovery after antibiotic treatment in a pet. Typically, said at least one probiotic is one or more selected from the group comprising Bifidobacterium lactis, Bifidobacterium animalis, Lactobacillus acidophilus, Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus casei, Lactobacillus plantarum and Enterococcus faecium.
Preferably, said at least one probiotic is Enterococcus faecium. Typically, said probiotic is 1 to 10χ10Λ10 per gram, preferably 3.5x10Λ10 per gram. It will be appreciated that the composition may comprise all or any of the listed supplements. The amount present may be any amount that is an effective amount of same supplement.
In one embodiment, the probiotic may be present in an amount of from about 0.1 w/w% to about 5.0 w/w%, preferably 0.10, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5 w/w %, preferably about 0.6 to 2.0 w/w%, preferably 0.87 w/w%.
Preferably, said probiotics are present in an amount of from about 0.5g to about 10g, preferably 0.5, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10 g per 100g. Preferably, 0.6g to 2g, preferably, 0.9g. Still preferred, said probiotics is present in an amount of about 0.87 g per 100g of composition.
The supplement or composition may comprise at least one prebiotic. There may be one to five prebiotics included, preferably, two, three or four. Prebiotics feed the beneficial microorganisms residing in the intestine. Prebiotics are non-digestible, fiber compounds. Preferably, said prebiotics are present in an amount of from about 0.5g to about 10g per 100g, preferably 0.5, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10g. Preferably, about 1g to about 5g, preferably, about 1g. Still preferred, said prebiotics is present in an amount of about 1.24 g per 100g of composition. The prebiotic may be Chicory (Vegetable) Extract. This may be Inulin or Inulin Dietary Fibre. Inulin is a soluble dietary fibre extracted from chicory roots by a natural process. It is a naturally sourced food ingredient. Inulin is a non-digestible oligosaccharide
The supplement or composition may comprise an effective amount of at least one vitamin. The composition may comprise from one to twelve vitamins. It will be appreciated that this includes two, three, four, five, six, seven, eight, nine, ten and eleven vitamins. A well balanced diet comprising the correct types and amounts of vitamins and minerals is essential for maintaining a healthy animal. The composition may comprise one or more of the group comprising vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12 and vitamin B5. It will be appreciated that this list is not limiting and that other vitamins could be included. Vitamin A plays a role in weight loss. Vitamin A and E are powerful antioxidants. Vitamin B-12 serves to aid cell growth and development. Vitamin D strengthens an animal’s bones and teeth. Vitamin K plays a role in liver health. Vitamin B1 has a role in normal carbohydrate metabolism. Typically, said composition comprises vitamin A. Typically, said composition comprises vitamin A, vitamin B complex, vitamin D and vitamin E. It will be appreciated that the composition may comprise all or any of the listed supplements. The amount present may be any amount that is an effective amount of same supplement.
The source of vitamin A may be retinol acetate. The source of vitamin B1 may be thiamine hydrochloride. The source of vitamin B2 may be riboflavin. The source of vitamin B3 may be niacinamide. The source of vitamin B5 may be calcium Dpantothenate. The source of vitamin B6 may be pyridoxine hydrochloride. The source of vitamin B9 may be folic acid. The source of vitamin B12 may be cyanocobalamin. The source of vitamin D may be cholecalciferol. The source of vitamin E may be DLalpha-tocopheryl acetate. The source of vitamin K1 may be phylloquinone. It will be appreciated that any suitable source may be included.
The vitamin may be present in an amount of from about 0.05 w/w % to about 10 w/w %. Typically, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10 w/w %. Preferably about 0.1 w/w% to about 5 w/w %, preferably about 0.15 w/w % to 1 w/w %, preferably 0.23 w/w% relative to the total weight of the composition on a dry solids basis.
Preferably, said vitamin A is present in an amount of from about 1 mg to about 50 mg per 100 g. Preferably, about 1 mg to about 10 mg, typically, 1.0, 1.5, 2, 2.5, 3, 3.5, 4,
4.5, 5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10 mg preferably, about 5mg. Still preferred, said vitamin A is present in an amount of about 4.66 mg per 100g of composition.
In one embodiment, said vitamin D is present in an amount of from about 5 pg to about 100pg per 100 g. Preferably, about 20 pg to about 60 pg, preferably, 20, 20.5, 21,
21.5, 22, 22.5, 23, 23.5, 24, 24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30,
30.5, 31, 31.5, 32, 32.5, 33, 33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39,
39.5, 40, 40.5, 41, 41.5, 42, 42.5, 43, 43.5, 44, 44.5, 45, 45.5, 46, 46.5, 47, 47.5, 48,
48.5, 49, 49.5 50, 50.5, 51, 51.5, 52, 52.5, 53, 53.5, 54, 54.5, 55, 55.5, 56, 56.5, 57,
57.5, 58, 58.5, 59, 59.5, 60pg . Preferably, about 42 pg. Still preferred, said vitamin D is present in an amount of about 41.84 pg per 100 g of composition.
Vitamin E may be present in an amount of from about 50 mg to about 150 mg per 100g. Preferably, about 70 mg to 120 mg, preferably, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93. 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120 mg. Typically, about 98 mg. Still preferred, said vitamin E is present in an amount of about 98.44 mg per 100 g of composition.
Vitamin K may be present in an amount of from about 250 pg to about 350 pg per 100g. Preferably, about 300 pg to about 320 pg, typically, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320 pg. Preferably, about 308 pg. Still preferred, said vitamin K is present in an amount of about 307.62 pg per 100g of composition.
Vitamin B1 may present in an amount of from about 1 mg to about 20 mg per 100 g, preferably, about 5.0 mg to about 10.0 mg, preferably, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 or 10 mg preferably, about 7 mg. Still preferred, said vitamin B1 is present in an amount of about 6.89 mg per 100g of composition.
Vitamin B2 may present in an amount of from about 1mg to about 50mg per 100 g, preferably, about 10.0 mg to about 20 mg, preferably, 10, 10.5, 11, 11.5, 12, 12.5, 13,
13.5, 14, 14.5, 15, 15.5, 16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5, 20 mg. Preferably, about 16 mg.
Vitamin B3 may present in an amount of from about 1 mg to about 100 mg per 100 g, preferably, about 20 mg to about 60 mg, preferably, 20, 20.5, 21, 21.5, 22, 22.5, 23,
23.5, 24, 24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30, 30.5, 31, 31.5, 32,
32.5, 33, 33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39, 39.5, 40, 40.5, 41,
41.5, 42, 42.5, 43, 43.5, 44, 44.5, 45, 45.5, 46, 46.5, 47, 47.5, 48, 48.5, 49, 49.5 50,
50.5, 51, 51.5, 52, 52.5, 53, 53.5, 54, 54.5, 55, 55.5, 56, 56.5, 57, 57.5, 58, 58.5, 59,
59.5, or 60 mg. Still preferred, said vitamin B3 is present in an amount of about 49.22 mg per 100 g of composition.
Vitamin B6 may be present in an amount of from about 1 mg to about 20 mg per 100 g, preferably, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13,13.5, 14,14.5, 15,15.5,16,16.5,17,17.5,18 18.5, 19, 19.5, 20 mg. Preferably, about 2 mg to about 10 mg, preferably, about 5 mg. Still preferred, said vitamin B6 is present in an amount of about 4.92 mg per 100 g of composition.
Vitamin B9 may be present in an amount of from about 500 pg to about 1000 pg per 100g. Preferably, about 700 pg to about 900 pg, typically, 710, 720, 730, 740, 750, 760, 770, 780,790, 800, 810, 820, 830, 840, 850, 860, 870, 880, 890, 900 pg. Preferably, about 837 pg. Still preferred, said vitamin B9 is present in an amount of about 836.72 pg per 100g of composition.
Vitamin B12 may be present in an amount of from about 10 pg to about 200 pg per 100g. Preferably, about 60 pg to about 120 pg, typically, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 150 pg, preferably, about 111 pg. Still preferred, said vitamin B12 is present in an amount of about 110.74 pg per 100g of composition.
Vitamin B5 may be present in an amount of from about 5 mg to about 100 mg per 100 g, preferably, about 20 mg to about 60 mg, 20, 20.5, 21, 21.5, 22, 22.5, 23, 23.5, 24,
24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30, 30.5, 31, 31.5, 32, 32.5, 33,
33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39, 39.5, 40, 40.5, 41, 41.5, 42,
42.5, 43, 43.5, 44, 44.5, 45, 45.5, 46, 46.5, 47, 47.5, 48, 48.5, 49, 49.5 50, 50.5, 51,
51.5, 52, 52.5, 53, 53.5, 54, 54.5, 55, 55.5, 56, 56.5, 57, 57.5, 58, 58.5, 59, 59.5, 60 mg, preferably, about 49 mg. Still preferred, said vitamin B9 is present in an amount of about 49.22 mg per 100g of composition.
The supplement or composition may comprise at least one mineral. The composition may comprise from one to twelve minerals. It will be appreciated that this includes two, three, four, five, six, seven, eight, nine, ten and eleven vitamins.The mineral may be one or more of the group comprising iron, zinc, copper, selenium, iodine and sodium. It will be appreciated that the composition may comprise all or any of the listed supplements. The amount present may be any amount that is an effective amount of same supplement. The mineral may be a salt.
The source of sodium may be sodium chloride. The source of iodine may be potassium iodide. The source of iron may be ferrous (iron II) gluconate. The source of copper may be copper gluconate. The source of zinc may be zinc citrate. The source of selenium may be selenium enriched yeast. It will be appreciated that any suitable source may be included.
Iron is essential for healthy blood and helps to transport oxygen throughout an animal’s body. Zinc plays a role in various metabolic pathways and is integral to the functioning of the immune system, hormone production and DNA synthesis. Selenium plays a role in the production of antioxidants. Copper is a vital part of many enzymes, such as those involves in iron metabolism and nervous system function.
Preferably, said iron is present in an amount of from about 20 mg to about 200 mg per 100 g, preferably, about 60 mg to about 120 mg, typically, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 150 mg, preferably, about 92 mg. Still preferred, said iron is present in an amount of about 92.28 mg per 100g of composition.
Preferably, said zinc is present in an amount of from about 100 mg to about 300 mg per 100 g, preferably, about 150 mg to about 200 mg, typically, 155, 160, 165, 170, 175, 180, 185, 190, 195, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, or 300 mg. Preferably, about 185 mg. Still preferred, said zinc is present in an amount of about 184.57 mg per 100g of composition.
Preferably, said copper is present in an amount of from about 1 mg to about 50 mg per 100 g, preferably, about 10 mg to about 20 mg, typically, 1.0, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10, 10.5, 11, 11.5, 12, 12.5, 13,13.5, 14,14.5, 15,15.5,16,16.5,17,17.5,18 18.5, 19, 19.5 or 20 mg. Preferably, 18 mg. Still preferred, said copper is present in an amount of about 18.46 mg per 100g of composition.
Preferably, said selenium is present in an amount of from about 500 pg to about 1500 pg per 100g. Preferably, about 800 pg to about 1200 pg, typically, 850, 900, 950, 1000, 1050, 1100, 1150, 1200 pg. Preferably, about 1107 pg. Still preferred, said selenium is present in an amount of about 1107.42 pg per 100g of composition.
Preferably, said iodine is present in an amount of from about 1500 pg to about 3500 pg per 100g. Preferably, about 2500 pg to about 2800 pg, typically, about 2500, 2550, 2600, 2650, 2700, 2750, or 2800 pg. Preferably, about 2707 pg. Still preferred, said iodine is present in an amount of about 2707.03 pg per 100 g of composition.
Preferably, said sodium is present in an amount of from about 1500 mg to about 3500 mg per 100g. Preferably, about 2500 mg to about 2800 mg, typically, about 2500, 2550, 2600, 2650, 2700, 2750, or 2800 mg. Preferably, 2658 mg. Still preferred, said sodium is present in an amount of about 2657.81 mg per 100g of composition.
It will be appreciated that all of the above supplements may be suitable for other functions apart from those assigned in relation thereto or listed.
The composition may further comprise at least one supplement for cardiovascular health. There may be one to five supplements included, preferably, two, three or four. This supplement may be L-arginine. The at least one supplement for cardiovascular health may be present in an amount of from about 0.5 w/w% to about 50 w/w%, preferably about 1 to about 40 w/w%, typically about 1, 1.5, 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6,
6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13,13.5, 14,14.5, 15,15.5,16,16.5,17,17.5,18 18.5, 19, 19.5, 20, 20.5, 21, 21.5, 22, 22.5, 23, 23.5, 24,
24.5, 25, 25.5, 26, 26.5, 27, 27.5, 28, 28.5, 29, 29.5, 30 30.5, 31, 31.5, 32, 32.5, 33,
33.5, 34, 34.5, 35, 35.5, 36, 36.5, 37, 37.5, 38, 38.5, 39, 39.5, or 40 w/w %, preferably about 5 w/w% to about 30 w/w% preferably, about 12.31 w/w%.
Preferably, said L-arginine is present in an amount of from about 1 g to about 20 g per 100g, preferably about 1.5, 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10,
10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5,16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5 or 20 g. Preferably, about 8 g to about 15 g, preferably, about 12 g. Still preferred, said L-arginine is present in an amount of about 12.31 g per 100g of composition.
The composition may further comprise a supplement for weight loss or weight management or treating obesity. There may be one to five supplements included, preferably, two, three or four. Typically, said supplement may be present in an amount of from about 0.5 w/w% to about 20 w/w %, preferably about 1 w/w% to about 10 w/w%, preferably about 3 w/w % relative to the total weight of the composition on a dry solids basis. Typically, said supplement is L-carnitine L-tartrate.
L- carnitine L-tartrate contributes to weight loss in obese animals or weight management. L-carnitine L-tartrate also helps to breakdown fatty acids in the liver which improves liver function. Preferably, said L- carnitine L-tartrate is present in an amount of from about 1.0 g to about 20 g per 10Og, preferably about 1.5, 2,2.5, 3, 3.5,
4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5, 15, 15.5,16, 16.5, 17, 17.5, 18, 18.5, 19, 19.5 or 20 g. Preferably, about 8 g to about 15 g, preferably, about 12 g. Still preferred, said L-arginine is present in an amount of about 12.31 g per 100 g of composition.
Preferably, the composition further comprises at least one supplement for bone health. There may be one to five supplements included, preferably, two, three or four. Typically, said supplement is calcium. Typically, said supplement may be present in an amount of from about .001 w/w% to about 5 w/w%, preferably, about .005 w/w% to about 2 w/w%, preferably .007 w/w % relative to the total weight of the composition on a dry solids basis. Calcium may be present in an amount of from about 1 mg to 20 mg per 100 g of the composition. Preferably, about 3 mg to about 15 mg, preferably, 3.5,
4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, 12, 12.5, 13, 13.5, 14, 14.5 or 15 mg. Still preferred, said calcium is present in an amount of about 7.88mg per 100 g of composition.
Preferably, the composition further comprises at least one supplement for kidney health and urinary tract health. There may be one to five supplements included, preferably, two, three or four. Typically, said supplement is taurine. Taurine may allow pets in particular cats to pass urine. Typically, said supplement may be present in an amount of from about 0.5 w/w% to about 10 w/w%, preferably, about 1.0 w/w% to about 5.0 w/w%, preferably 3.7 w/w % relative to the total weight of the composition on a dry solids basis.
Taurine may be present in an amount of from about 0.5 g to 20 mg per 100 g of the composition. Preferably, about 1 mg to about 10 mg, preferably, 1.5, 2, 2.5, 3, 3.5, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, or 10 g. Still preferred, said taurine is present in an amount of about 3.69 g per 100 g of composition.
In a preferred embodiment, said composition comprises at least the following components: glucosamine sulphate, glutamine, digestive enzymes, prebiotics, probiotics, vitamin A, and Iodine.
In a preferred embodiment, said composition comprises at least the following components: glucosamine sulphate, glutamine, omega 3, flaxseed oil powder, digestive enzymes, prebiotics, probiotics, vitamin A, vitamin B1, vitamin B2, Iodine and iron.
In an alternative embodiment, said composition comprises at least the following components: glucosamine sulphate, glutamine, omega 3, flaxseed oil powder, milk thistle, digestive enzymes, prebiotics, probiotics, vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B9, vitamin B6, Iodine, and iron.
In an alternative embodiment, said composition comprises at least the following components: glucosamine sulphate, glutamine, omega 3, flaxseed oil powder, milk thistle, pine bark extract, digestive enzymes, L-carnitine L-tartrate, prebiotics, probiotics, vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B9, vitamin B6, vitamin B12, Iodine, zinc, copper and iron.
It will be appreciated that the supplements or components of the above compositions may be present in the following amounts: vitamin A in an amount of from 2 mg to 6 mg; vitamin D in an amount of from 30 pg to 50 pg preferably 40 pg to 45 pg; vitamin E in an amount of 95 mg to 100 mg; vitamin K in an amount of 290 pg to 330 pg preferably 303 to 308 pg; vitamin B1 in an amount of 4 mg to 8 mg; vitamin B2 in an amount of 14 mg to 18 mg; vitamin B3 in an amount of 46 mg to 52 mg; vitamin B6 in an amount of 2 to 6 mg; vitamin B9 (folic acid) in an amount of 800 pg to 850 pg, preferably 832 pg to 839 pg; vitamin B12 in an amount of 90 pg to 130 pg, preferably 108 pg to 113 pg; vitamin B5 in an amount of 46 mg to 52 mg; Iron in an amount of from 90 mg to 95 mg; Zinc in an amount of from 182 mg to 188 mg; Copper in an amount of from 15 mg to 21 mg; Selenium in an amount of from 1080 to 1150 pg, preferably 1103 pg to 1110 pg; Iodine in an amount of from 2680 pg to 2750, preferably 2702 pg to 2710 pg; Sodium in an amount of from 2620 mg to 2690 mg, preferably 2652 mg to 2660 mg; L-Arginine in an amount of from 10 to 14 g; L-Citrulline DL- Malate in an amount of from 1 to 5 g; LGlutamine in an amount of from 34 g to 39 g; L-Carnitine L-Tartrate in an amount of from 1g to 4 g; L-Lysine in an amount of from 1g to 5 g; Glucosamine Sulphate 2KCL in an amount of from 2 to 8 g; Methyl-Sulfonyl-Methane (MSM) in an amount of from 2 to 8g; Chondroitin Sulphate (Bovine) in an amount of from 1g to 4 g; Pine Bark Extract in 10g to 14g; Omega 3 in an amount of 1g to 4 g; Milk Thistle (Silybum Marianum) in an amount of 1 g to 3 g; Digestive Enzymes in an amount of 0.5 g to 2g; Prebiotics in an amount of 0.5g to 3g and Probiotics in an amount of 0.5 g to 3g, per 100 g of composition.
In one embodiment, said composition comprise vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DLMalate, L-Glutamine, L-Carnitine L-Tartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder,
Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics.
It is particular advantageous to provide a composition comprising vitamin A in an amount of from 2 mg to 6 mg, vitamin D in an amount of from 30 pg to 50 pg, preferably 40 pg to 45 pg, vitamin E in an amount of 95 mg to 100 mg, vitamin K in an amount of 290 pg to 330 pg, preferably 303 to 308 pg, vitamin B1 in an amount of 4 mg to 8 mg, vitamin B2 in an amount of 14 mg to 18 mg, vitamin B3 in an amount of 46 mg to 52 mg, vitamin B6 in an amount of 2 to 6 mg, vitamin B9 (folic acid) in an amount of 800 pg to 850 pg, preferably 832 pg to 839 pg , vitamin B12 in an amount of 90 pg to 130 pg , preferably 108 pg to 113 pg, vitamin B5 in an amount of 46 mg to 52 mg, Iron in an amount of from 90 mg to 95 mg, Zinc in an amount of from 182 mg to 188 mg, Copper in an amount of from 15 mg to 21 mg, Selenium in an amount of from 1080 to 1150 pg, preferably 1103 pg to 1110 pg, Iodine in an amount of from 2680 pg to 2750, preferably 2702 pg to 2710 pg, Sodium in an amount of from 2620 mg to 2690 mg, preferably 2652 mg to 2660 mg, L-Arginine in an amount of from 10 to 14 g, L-Citrulline DL- Malate in an amount of from 1 to 5g, L-Glutamine in an amount of from 34g to 39 g, L-Carnitine L-Tartrate in an amount of from 1g to 4 g, L-Lysine in an amount of from 1g to 5 g, Glucosamine Sulphate 2KCL in an amount of from 2 to 8 g, Methyl-SulfonylMethane (MSM) in an amount of from 2 to 8 g, Chondroitin Sulphate (Bovine) in an amount of from 1g to 4 g, Pine Bark Extract in 10g to 14g, Omega 3 in an amount of 1g to 4 g, Milk Thistle (Silybum Marianum) in an amount of 1g to 3g, Digestive Enzymes in an amount of 0.5g to 2g, Prebiotics in an amount of 0.5g to 3g and Probiotics in an amount of 0.5g to 3g, per 100 g of composition.
These compositions are particularly effective in dogs.
In one embodiment said composition comprises vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DLMalate, L-Glutamine, L-Carnitine L-Tartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder, Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics, calcium, omega 6 and taurine.
It is particular advantageous to provide a composition comprising vitamin A in an amount of from 2 mg to 6 mg, vitamin D in an amount of from 30 pg to 50 pg, preferably 40 pg to 45 pg, vitamin E in an amount of 95 mg to 100 mg, vitamin K in an amount of 290 pg to 330 pg, preferably 303 to 308 pg, vitamin B1 in an amount of 4 mg to 8 mg, vitamin B2 in an amount of 14 mg to 18 mg, vitamin B3 in an amount of 46 mg to 52 mg, vitamin B6 in an amount of 2 to 6 mg, vitamin B9 (folic acid) in an amount of 800 pg to 850 pg, preferably 832 pg to 839 pg , vitamin B12 in an amount of 90 pg to 130 pg , preferably 108 pg to 113 pg, vitamin B5 in an amount of 46 mg to 52 mg, Iron in an amount of from 90 mg to 95 mg, Zinc in an amount of from 182 mg to 188 mg, Copper in an amount of from 15 mg to 21 mg, Selenium in an amount of from 1080 to 1150 pg, preferably 1103 pg to 1110 pg, Iodine in an amount of from 2680 pg to 2750, preferably 2702 pg to 2710 pg, Sodium in an amount of from 2620 mg to 2690 mg, preferably 2652 mg to 2660 mg, L-Arginine in an amount of from 10 to 14 g, L-Citrulline DL- Malate in an amount of from 1 to 5g, L-Glutamine in an amount of from 34g to 39 g, L-Carnitine L-Tartrate in an amount of from 1g to 4 g, L-Lysine in an amount of from 1g to 5 g, Glucosamine Sulphate 2KCL in an amount of from 2 to 8 g, Methyl-SulfonylMethane (MSM) in an amount of from 2 to 8 g, Chondroitin Sulphate (Bovine) in an amount of from 1g to 4 g, Pine Bark Extract in 10g to 14g, Omega 3 in an amount of 1g to 4 g, Milk Thistle (Silybum Marianum) in an amount of 1g to 3g, Digestive Enzymes in an amount of 0.5g to 2g, Prebiotics in an amount of 0.5g to 3g and Probiotics in an amount of 0.5g to 3g, Taurine in an amount of 1 to 5 g, Omega 6 in an amount of 0.5g to 2g, calcium in an amount of between 5 and 10 mg, per 100 g of composition.
These compositions may be particularly effective in cats.
The amount of the supplements as described in the composition of the invention may be an effective amount.
The composition is advantageously in the form of a dry powder. This allows easy administration to a pet as the dry powder is suitable for addition to a food product. It may be granules. In use the composition is in a sachet or capsule.
The sachet may comprise 1 to 20 g of the composition, preferably 7 to 15 g, preferably 8g, preferably 8.06g. This composition is particularly suitable for administration to a dog.
The sachet may comprise 1 to 20 g of the composition, preferably 2 to 15g, preferably 2 to 6 g, preferably 5.03g. This composition is particularly suitable for administration to a cat.
Conveniently, the composition is administered in a dose of once per day. Preferably, the composition is for oral administration to a pet once per day. Typically, said administration is at any time of day. Preferably, said administration is in the morning. Alternatively, said administration is in the evening.
A food product is also provided comprising the composition. The food product may be any pet food product, such as a dry or wet food product or a liquid.
The invention also provides a method for treating or alleviating the symptoms of a disease or condition in a pet. The method comprises administering the composition of the invention and as described above to a pet. The composition may be administered in powder or granule form by adding the composition to pet food to be consumed by the pet. The powder or granules may be in a sachet and the contents added to the pet food. The pet food may be wet pet food, dry pet food or liquid, such as water. It will be appreciated that the composition may be administered once a day. The composition should preferably be administered to a pet once a day every day to maintain a balanced diet. The composition may be administered directly to the pet.
The invention also provides the composition of the invention and/or as described above for use in a method of treating a disease or condition.
The invention also provides the composition of the invention and/or as described above for use in a method of alleviating the symptoms of a disease or condition.
The invention also provides the composition of the invention and/or as described above for use in a method of preventing a disease or condition.
The disease or conditions may be those as described herein.
The words “comprises/comprising” and the words “having/including” when used herein with reference to the present invention are used to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination.
Claims (41)
1. A composition or dietary supplement comprising at least one supplement for joint health, at least one supplement for digestive system health, at least one probiotic, at least one prebiotic, at least one vitamin and at least one mineral.
2. The composition of claim 1, further comprising at least one supplement for cardiovascular health.
3. The composition of claim 1 or 2, further comprising at least one supplement for weight loss.
4. The composition of any one of the preceding claims further comprising at least one supplement for energy.
5. The composition of any one of the preceding claims further comprising at least one supplement for urinary tract and/or kidney health.
6. The composition of any one of the preceding claims further comprising at least one supplement for liver health.
7. The composition of any one of the preceding claims further comprising at least one supplement for bone health.
8. The composition of any one of the preceding claims, wherein the vitamin is present in an amount of from about 0.05 w/w % to about 10 w/w % relative to the total weight of the composition on a dry solids basis.
9. The composition of any one of the preceding claims, wherein the at least one mineral is present in an amount of from about 0.01 w/w % to about 10 w/w % relative to the total weight of the composition on a dry solids basis.
10. The composition of any one of the preceding claims, wherein the at least one supplement for joint health is present in an amount of from about 0.2 w/w % to about 85 w/w % relative to the total weight of the composition on a dry solids basis.
11. The composition of any one of the preceding claims, wherein the at least one at least one supplement for digestive health is present in an amount of from about 0.05 w/w% to about 20 w/w % relative to the total weight of the composition on a dry solids basis.
12. The composition of any one of the preceding claims, wherein the at least one probiotic is present in an amount of from about 0.1 w/w% to about 5 w/w% relative to the total weight of the composition on a dry solids basis.
13. The composition of any one of the preceding claims, wherein the at least one prebiotic is present in an amount of from about 0.5 w/w% to about 10 w/w% relative to the total weight of the composition on a dry solids basis.
14. The composition of any one of claims 2 to 13, wherein the at least one supplement for cardiovascular health may be present in an amount of from about 0.5 w/w% to about 50.0 w/w% relative to the total weight of the composition on a dry solids basis.
15. The composition of any one of claims 3 to 14, wherein the at least one supplement for weight loss, or treating or preventing obesity is present in an amount of from about 0.5 w/w% to about 20 w/w % relative to the total weight of the composition on a dry solids basis.
16. The composition of any one of claims 4 to 15, wherein the at least one supplement for energy is present in an amount of from about 0.05 w/w% to about 20 w/w % relative to the total weight of the composition on a dry solids basis.
17. The composition of any one of claims 5 to 16, wherein the at least one supplement for urinary tract health or kidney health is present in an amount of from 0.5 w/w% to about 10 w/w% relative to the total weight of the composition on a dry solids basis.
18. The composition of any one of claims 6 to 17, wherein the at least one supplement for liver health is present in an amount of from about about 0.05 w/w% to about 20 w/w % relative to the total weight of the composition on a dry solids basis.
19. The composition of any one of claims 7 to 18, wherein the at least one supplement for bone health is present in an amount of from about about 0.001 w/w% to about 5 w/w % relative to the total weight of the composition on a dry solids basis.
20. The composition of any one of the preceding claims wherein said at least one vitamin is one or more selected from the group comprising vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12 and vitamin B5.
21. The composition of any one of the preceding claims wherein said at least one mineral is one or more selected from the group comprising iron, zinc, copper, selenium, iodine and sodium.
22. The composition of any one of the preceding claims wherein said at least one probiotic is one or more selected from the group comprising Bifidobacterium lactis, Bifidobacterium animalis, Lactobacillus acidophilus, Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus casei, Lactobacillus plantarum and Enterococcus faecium.
23. The composition of any one of the preceding claims wherein said at least one prebiotic is selected from the group comprising a fiber composition and chicory extract.
24. The composition of any one of the preceding claims wherein said at least one supplement for joint health is one or more selected from the group comprising glucosamine sulphate, Methyl-Sulfonyl-Methane (MSM), chondroitin sulphate, pine bark extract, flax seed oil powder, omega 3, L-glutamine, and L-lysine.
25. The composition of any one of the preceding claims wherein said at least one supplement for digestive system health is one or more digestive enzymes.
26. The composition of any one of the preceding claims wherein said at least one supplement for cardiovascular health is L-arginine.
27. The composition of any one of the preceding claims wherein said at least one supplement for treating or preventing obesity is L-carnitine L-tartrate.
28. The composition of any one of the preceding claims wherein said at least one supplement for energy is L-citrulline DL-malate.
29. The composition of any one of the preceding claims wherein said supplement for urinary tract health or kidney health is taurine.
30. The composition of any one of the preceding claims wherein said supplement for liver health is milk thistle.
31. The composition of any one of the preceding claims wherein said supplement for bone health is calcium.
32. The composition of any one of the preceding claims comprising vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DL Malate, L-Glutamine, L-Carnitine LTartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder, Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics.
33. The composition of any one of the preceding claims comprising vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 (folic acid), vitamin B12, vitamin B5, Iron, Zinc, Copper, Selenium, Iodine, Sodium, L-Arginine, L-Citrulline DL- Malate, L-Glutamine, L-Carnitine L32
Tartrate L-Lysine, Glucosamine Sulphate 2KCL, Methyl-Sulfonyl-Methane (MSM), Chondroitin Sulphate (Bovine), Pine Bark Extract, Flax Seed Oil Powder, Omega 3 DHA Powder, Milk Thistle (Silybum Marianum), Digestive Enzymes, Prebiotics and Probiotics, calcium, omega 6 and taurine.
34. The composition of any one of the preceding claims wherein said composition is in the form of a dry powder.
35. The composition of any one of the preceding claims for use in the treatment and/or alleviation of the symptoms, of a disease or condition in a pet.
36. The composition of any one of the preceding claims for use in the prevention of a disease or condition in a pet.
37. The composition for use of claim 26 or 27, wherein said use is by oral administration of said composition once per day.
33. The composition for use of any one of claims 26 to 28, wherein said disease or condition is selected from the group comprising a joint condition, a digestive system condition, a cardiovascular condition, a condition associated with under or over nutrition, obesity, diabetes, and cancer.
39. The composition of any one of the preceding claims wherein said pet is a dog.
40. The composition of any one of the preceding claims wherein said pet is a cat.
41. The composition substantially as described herein with reference to the figures.
Intellectual
Property
Office
Application No: GB1602804.5
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1602804.5A GB2558170A (en) | 2016-02-17 | 2016-02-17 | Dietary supplement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1602804.5A GB2558170A (en) | 2016-02-17 | 2016-02-17 | Dietary supplement |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201602804D0 GB201602804D0 (en) | 2016-03-30 |
GB2558170A true GB2558170A (en) | 2018-07-11 |
Family
ID=55697813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1602804.5A Withdrawn GB2558170A (en) | 2016-02-17 | 2016-02-17 | Dietary supplement |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2558170A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4000626A1 (en) * | 2020-11-16 | 2022-05-25 | concrete flowers GmbH | Pharmaceutical preparation |
US11878039B1 (en) | 2023-03-01 | 2024-01-23 | King Faisal University | Composition for treating Irritable Bowel Syndrome |
EP4103174A4 (en) * | 2020-02-14 | 2024-03-13 | Npi, Llc | Smartcore compositions and methods |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
US20080260708A1 (en) * | 2007-04-19 | 2008-10-23 | Hall Mickey A | Methods and related systems and formulations to normalize and improve human body chemistry and healing ability |
US20130216521A1 (en) * | 2012-02-03 | 2013-08-22 | Melinda Fernyhough Culver | Dietary supplement for enhancing animal health |
CN104256206A (en) * | 2014-10-24 | 2015-01-07 | 云南广联畜禽有限公司 | Compound feed for improving pork quality |
-
2016
- 2016-02-17 GB GB1602804.5A patent/GB2558170A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
US20080260708A1 (en) * | 2007-04-19 | 2008-10-23 | Hall Mickey A | Methods and related systems and formulations to normalize and improve human body chemistry and healing ability |
US20130216521A1 (en) * | 2012-02-03 | 2013-08-22 | Melinda Fernyhough Culver | Dietary supplement for enhancing animal health |
CN104256206A (en) * | 2014-10-24 | 2015-01-07 | 云南广联畜禽有限公司 | Compound feed for improving pork quality |
Non-Patent Citations (3)
Title |
---|
The Wholistic Pet Health Care Supplements, The Wholistic Pet, 17 March 2015. Available online at https://web.archive.org/web/20150317073342/http://www.thewholisticpet.com/canine-product-line/health-care-supplements.html [Accessed 27 October 2016] * |
Wholistic Canine Complete Joint Mobility, The Wholistic Pet, 14 May 2015. Available online at https://web.archive.org/web/20150514235421/http://www.thewholisticpet.com/wholistic-canine-complete-joint-mobilitytm.html [Accessed 27 October 2016] * |
Wholistic Canine Complete, The Wholistic Pet, 11 March 2015. Available online at https://web.archive.org/web/20150311225006/http://www.thewholisticpet.com/canine-product-line/health-care-supplements/wholistic-canine-completetm.html [Accessed 27 October 2016] * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4103174A4 (en) * | 2020-02-14 | 2024-03-13 | Npi, Llc | Smartcore compositions and methods |
EP4000626A1 (en) * | 2020-11-16 | 2022-05-25 | concrete flowers GmbH | Pharmaceutical preparation |
US11878039B1 (en) | 2023-03-01 | 2024-01-23 | King Faisal University | Composition for treating Irritable Bowel Syndrome |
US11883442B1 (en) | 2023-03-01 | 2024-01-30 | King Faisal University | Composition for treating irritable bowel syndrome |
Also Published As
Publication number | Publication date |
---|---|
GB201602804D0 (en) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2485800C1 (en) | System for domestic animals feeding | |
US8529965B2 (en) | Compositions and methods for altering stool quality in an animal | |
JP2009518015A (en) | Methods for altering stool quality and / or frequency of defecation | |
Kozłowska et al. | 2. Beneficial aspects of inulin supplementation as a fructooligosaccharide prebiotic in monogastric animal nutrition–A review | |
JP2016505024A (en) | Baby food composition containing bacteria that produce viable propionic acid | |
RU2483570C2 (en) | Methods for modification of fodder consumption modifying nutrients digestibility and stool quality and frequency | |
US10758562B2 (en) | Gel formulation for the prevention and treatment of gastrointestinal distress in horses and other species | |
GB2558170A (en) | Dietary supplement | |
US20200397838A1 (en) | Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions | |
JP2009528031A (en) | Process for promoting overall health in animals | |
RU2496487C2 (en) | Method for reducing lipid absorption in animals | |
JP5473909B2 (en) | Compositions and methods for altering the quality of animal feces | |
ES2691981T3 (en) | Treatment of diarrhea and post-weaning diarrhea with resistant potato starch | |
JP2014505679A (en) | Methods and compositions for prevention and treatment of osteoarthritis | |
JP2011529881A (en) | Methods and compositions for preventing, alleviating or treating damage resulting from ischemia and ischemia-like conditions | |
CN115666260A (en) | Compositions and methods for digestive health in animals | |
RU2444907C2 (en) | Fodder composition, kit and method for animal bowels action quality modification (versions) | |
US20230000901A1 (en) | Method for preventing or treating gastrointestinal distress in humans using mastic gum compositions | |
Greco | GI wish I'd thought of that: management of complicated feline internal medicine cases-Part 2. | |
Švarcová et al. | Influence of Feed Supplements to Selected Microelements in the Blood Calves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |